Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01964794 · ClinicalTrials.gov registry record
Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 60
- Enrollment target
NCT01964794: Completed study, sponsored by University of Arkansas.
NCT01964794 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01964794 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Clinically relevant biomarkers for warfarin identified in this study will provide crucial leads for subsequent studies to assess their predictive value during anticoagulant therapy. This knowledge will aid stratifying risk among patients to improve therapeutic outcomes and decrease adverse drug events and associated health care costs. Collectively, these efforts will provide a critical foundation for future research using a metabolite biomarker strategy in a clinical setting to revolutionize warfarin therapy. Through its application, a real-time assessment of warfarin metabolism for each patient could lead to a truly personalized dosing strategy and improve patient safety for this life-saving drug.
Primary Outcome
Based on a single blood draw, identify metabolite biomarkers for achieving a stable target anticoagulant response among patients at a maintenance dose of warfarin.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-10 |
What the finished NCT01964794 record still lists
NCT01964794 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01964794 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01964794 about?
NCT01964794 is a clinical study titled "Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling". Clinically relevant biomarkers for warfarin identified in this study will provide crucial leads for subsequent studies to assess their predictive value during anticoagulant therapy. This knowledge will aid stratifying risk among patients to improve therapeutic outcomes and decrease adverse drug even...
What is the current status of trial NCT01964794?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2012-05. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT01964794?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia